|
FDASmart and Nlinks jointly conclude first anti-counterfeiting forum
Our News Bureau - Mumbai
 FDASmart,
a US and India based management and pharmaceutical consulting/training company
recently held its first anti-counterfeiting forum in Mumbai on March 4, 2011
in Mumbai in association with Nlinks, Mumbai.
The theme for the forum was to acknowledge the serious threat of counterfeit
drugs to us all specifically targeting the issues in India including latest
announcements from DGFT and DCC/DCGI on bar coding and serialisation requirements
for Indian pharmaceutical manufacturers. A world-class group of experts from
the US, Europe and India came together to drive home not only the problems but
present innovative solutions to win the war against counterfeiters who seem
to get more sophisticated by the day. Speakers included various stakeholders
in the pharma industry including GlaxoSmithKline's Supply Chain manager, Sproxil’s
consumer-based anti-counterfeiting solution that is used in nationwide in Nigeria
(praised by Pres. Clinton), Cognex, Bilcare, Systech, ACG with is capsule encoded
system, IDMA, Ram Banarse Assistant commissioner, FDA Maharashtra and many more.
 |
 |
The event was used by Tata Teleservices Ltd (TTSL) to announce
the pre-launch of its mobile health solutions as part of their nationwide VAS
services in India. The forum’s panel discussion moderated by FDASmart’s
CEO-Founder Ram Balani explored in-depth the controversial DGFT and DCGI bar
coding and serialisation mandates. A vibrant and sometime controversial discussion
was followed with audience participation, a trademark of all FDASmart events.
|
